Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting

Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy

NCT01538680 ·Status: NO_LONGER_AVAILABLE

Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer

NCT01875380 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma .

NCT02788006 ·Status: COMPLETED ·Phase: PHASE2

A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment

NCT06137170 ·Status: COMPLETED

RE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins.

NCT04920422 ·Status: COMPLETED

Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers

NCT06425133 ·Status: RECRUITING ·Phase: PHASE2

Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy

NCT01959269 ·Status: COMPLETED

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

NCT00005085 ·Status: COMPLETED ·Phase: PHASE2

Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer

NCT04534218 ·Status: COMPLETED ·Phase: PHASE2

Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma

NCT02023333 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib

NCT02699073 ·Status: COMPLETED ·Phase: PHASE2

Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC

NCT02835924 ·Status: COMPLETED ·Phase: PHASE2

Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy

NCT01853319 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib

NCT04874207 ·Status: COMPLETED ·Phase: PHASE4

A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer

NCT02402036 ·Status: TERMINATED ·Phase: PHASE2

Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer

NCT02465502 ·Status: COMPLETED ·Phase: PHASE2

Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib

NCT03386825 ·Status: COMPLETED

Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab

NCT02175654 ·Status: TERMINATED ·Phase: PHASE2

Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy

NCT01103323 ·Status: COMPLETED ·Phase: PHASE3

Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer

NCT01996969 ·Status: COMPLETED ·Phase: NA

A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy

NCT02053376 ·Status: COMPLETED ·Phase: PHASE2

Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST

NCT02638766 ·Status: COMPLETED ·Phase: PHASE2

Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy

NCT01677884 ·Status: COMPLETED ·Phase: PHASE2

Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer

NCT02619435 ·Status: UNKNOWN ·Phase: PHASE2

Evaluation of Bevacizumab in Combination With First-Line Chemotherapy in Patients Aged 75 Years of Older With Metastatic Colorectal Adenocarcinoma (Prodige20)

NCT01900717 ·Status: COMPLETED ·Phase: PHASE2